We are live on ! Find out more
NSPR icon

InspireMD

15 hedge funds and large institutions have $272K invested in InspireMD in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

300% more capital invested

Capital invested by funds: $68K → $272K (+$204K)

88% more funds holding

Funds holding: 815 (+7)

0.09% more ownership

Funds ownership: 0.16%0.25% (+0.09%)

Holders
15
Holders Change
+7
Holders Change %
+87.5%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NSPR Hedge Fund Activity: Q2 2020 in Review

15 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2020, worth a combined $272K — up 300% from $68K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NSPR positions and 2 closed out — a net gain of 7 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Wedbush Securities, adding an estimated $55.4K. The largest seller was Barclays, exiting entirely with an estimated $18K sold.

  • 15 institutional investors held InspireMD (NSPR) as of Q2 2020, up from 8 in Q1 2020.
  • Funds reported $272K of InspireMD stock for Q2 2020, up 300% quarter-over-quarter.
  • 9 funds opened new InspireMD positions in Q2 2020 and 2 closed out, a net change of +7 holders.
  • The largest InspireMD buyer in Q2 2020 was Wedbush Securities, an estimated $55.4K added.
  • The largest InspireMD seller in Q2 2020 was Barclays, an estimated $18K sold.

Based on aggregated 13F filings for Q2 2020.